A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse
Bronwyn A. O’Brien(University of Technology Sydney), Jan Dutz(BC Children's Hospital), YiQun Zhang(University of British Columbia), Jason Bush(University of British Columbia), Xuan Geng(Simon Fraser University), Gang� Li(Brown Foundation), Mehran Ghoreishi(University of British Columbia), Diane T. Finegood(Simon Fraser University), Catherine H. Orteu(Royal Free London NHS Foundation Trust), Yongqian Huang(Simon Fraser University)
Cited by 115
Related Papers
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes
|Journal of the European Academy of Dermatology and Venereology|2017|262
Interferon‐β mediates stromal cell rescue of T cells from apoptosis
|European Journal of Immunology|1999|199
Fabry disease and the skin: data from FOS, the Fabry outcome survey
|British Journal of Dermatology|2007|178
Metformin as an Adjunct Therapy in Adolescents With Type 1 Diabetes and Insulin Resistance
|Diabetes Care|2003|162
Expansion of Antigen-Specific Regulatory T Cells with the Topical Vitamin D Analog Calcipotriol
|The Journal of Immunology|2009|148